Astellas Venture Management (AVM) is the wholly-owned venture capital organization within Astellas, dedicated to supporting pre-clinical, cutting-edge science that can bring value to patients. Over 15 years, AVM has provided equity investments to private, early-stage companies developing therapeutic programs and platform technologies, helping them advance their innovations faster. AVM is a strategic investor, making investments in science that will enhance the current Astellas R&D pipeline or catalyze new research directions.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions